Athenex ATNX
$ 0.2
-23.39%
Annual report 2022
added 03-20-2023
Country |
USA |
IPO year |
2017 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Johnson Lau |
Employees in the company |
574 |
Shares |
6.54 M |
Market Cap[1] |
$ 1.76 M |
EBITDA (LTM) |
$ -101 M |
P/E (LTM) |
-2.62 |
P/S (LTM) |
0.17 |
EPS (LTM) |
-0.96 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.